AirXpanders (Palo Alto, California) reported that the first patient has been treated in the AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction(EXPAND trial. XPAND is a prospective, randomized, controlled, open-label pivotal study of the company's AeroForm breast tissue expansion device in mastectomy patients undergoing breast reconstruction. Read More
